ARECOR THERAPEUTICS PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155 GBX | -2.21% |
|
+13.55% | -15.07% |
| 05-20 | Arecor Therapeutics' Investigational Insulin Shows Fast Absorption in Early-stage Study | MT |
| 05-20 | Arecor Therapeutics hails positive profile for insulin AT278 | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 61.73M | - | |||||
| 55.07B | - | |||||
| 40.22B | ||||||
| 41.79B | ||||||
| 28.17B | ||||||
| 26.28B |
